Help Dr. Cecilia Bove launch her FQ toxicity project! - survey
Verfasst: 29.08.2020, 07:14
Dr. Cecilia Bove is a Neuroscientist with Bucknell University in the States:
https://www.researchgate.net/profile/Cecilia_Bove
She has several publications about vagus nerve in neurodegenerative diseases and has been inspired by a story of a floxie acquaintance. I am attaching the poster that has been circulating in the FQT group. Please email her directly to get the survey link at cecilia.bove@bucknell.edu. She needs ~500 participants with new GI issues post FQs, regardless of the time of onset. The more participants, the better chance that she will receive funding for this, I think.
In her own words,
The purpose of this research is to gain insight into a possible correlation between the intake of fluoroquinolones and permanent damage to the brain areas that regulate the gastrointestinal tract. I am a neuroscientist, and my PhD focused on this issue in the context of another illness, Parkinson's Disease. My goal is to eventually examine the molecular changes that occur following the administration of fluoroquinolones in animal models, but I would first like to understand the nature of gastrointestinal symptoms that arise after FQLs administration. Despite being fairly known that this is the case, very little research is available describing the nature of gastrointestinal issues. A fairly easy, not time-consuming way to assess this, is through the survey I am inviting you all to fill. It is a short (15 minutes) long survey, in which we will ask you some questions about your gut health. The data gathered from the survey is completely anonymized to protect your identity and stored confidentially solely for analysis purposes. My goal is to gather enough responses (~500) to publish in a peer-reviewed journal and, based on the result, reach out to the FDA and the European Drug Administration to modify the current warnings on FQLs.
This would ultimately be my first paper published on gut health and FQLs. As I said earlier, my expertise was on Parkinson's Disease, and now that I am a faculty at Bucknell University I have the opportunity to pursue my own research plans. My laboratory is now composed of me and two undergraduate students. We have all undergone training to do human research according to the Institutional Review Board (IRB) to ensure the protection and quality of this type of research. If you are interested in reading more about my previous research, you can find me on pubmed, researchgate, or google scholar. My main co-author was Travagli R.A., so that would help you narrow down the results.
https://www.researchgate.net/profile/Cecilia_Bove
She has several publications about vagus nerve in neurodegenerative diseases and has been inspired by a story of a floxie acquaintance. I am attaching the poster that has been circulating in the FQT group. Please email her directly to get the survey link at cecilia.bove@bucknell.edu. She needs ~500 participants with new GI issues post FQs, regardless of the time of onset. The more participants, the better chance that she will receive funding for this, I think.
In her own words,
The purpose of this research is to gain insight into a possible correlation between the intake of fluoroquinolones and permanent damage to the brain areas that regulate the gastrointestinal tract. I am a neuroscientist, and my PhD focused on this issue in the context of another illness, Parkinson's Disease. My goal is to eventually examine the molecular changes that occur following the administration of fluoroquinolones in animal models, but I would first like to understand the nature of gastrointestinal symptoms that arise after FQLs administration. Despite being fairly known that this is the case, very little research is available describing the nature of gastrointestinal issues. A fairly easy, not time-consuming way to assess this, is through the survey I am inviting you all to fill. It is a short (15 minutes) long survey, in which we will ask you some questions about your gut health. The data gathered from the survey is completely anonymized to protect your identity and stored confidentially solely for analysis purposes. My goal is to gather enough responses (~500) to publish in a peer-reviewed journal and, based on the result, reach out to the FDA and the European Drug Administration to modify the current warnings on FQLs.
This would ultimately be my first paper published on gut health and FQLs. As I said earlier, my expertise was on Parkinson's Disease, and now that I am a faculty at Bucknell University I have the opportunity to pursue my own research plans. My laboratory is now composed of me and two undergraduate students. We have all undergone training to do human research according to the Institutional Review Board (IRB) to ensure the protection and quality of this type of research. If you are interested in reading more about my previous research, you can find me on pubmed, researchgate, or google scholar. My main co-author was Travagli R.A., so that would help you narrow down the results.